最后，研究小组又分别检查24名患乳腺癌和直肠癌的患者，在这些患者的肿瘤中寻找通过层层筛选所得知的突变基因。
Finally, the team found 24 more people with breast cancer and 24 with colorectal cancer, and looked at their tumours for the mutant genes that had got through the screening.
这种细胞级的诊断系统可以被应用于药物筛选或者可能被用于疾病治疗，在杀死肿瘤细胞的同时保留健康细胞。
The cell-level diagnostic system could be used for drug screening or perhaps for disease treatment, killing tumors while leaving healthy cells alone.
为了鉴定AKT1基因突变，研究人员共筛选了150份肿瘤样本，其中乳腺癌、直结肠癌和卵巢癌各50份。
To identify the AKT1 mutation, the researchers analyzed 150 tumor samples from patients with either breast, colorectal or ovarian cancer (50 samples from each tumor type).
应用推荐